Literature DB >> 28366720

Brain energy metabolism spurns fatty acids as fuel due to their inherent mitotoxicity and potential capacity to unleash neurodegeneration.

Peter Schönfeld1, Georg Reiser2.   

Abstract

The brain uses long-chain fatty acids (LCFAs) to a negligible extent as fuel for the mitochondrial energy generation, in contrast to other tissues that also demand high energy. Besides this generally accepted view, some studies using cultured neural cells or whole brain indicate a moderately active mitochondrial β-oxidation. Here, we corroborate the conclusion that brain mitochondria are unable to oxidize fatty acids. In contrast, the combustion of liver-derived ketone bodies by neural cells is long-known. Furthermore, new insights indicate the use of odd-numbered medium-chain fatty acids as valuable source for maintaining the level of intermediates of the citric acid cycle in brain mitochondria. Non-esterified LCFAs or their activated forms exert a large variety of harmful side-effects on mitochondria, such as enhancing the mitochondrial ROS generation in distinct steps of the β-oxidation and therefore potentially increasing oxidative stress. Hence, the question arises: Why do in brain energy metabolism mitochondria selectively spurn LCFAs as energy source? The most likely answer are the relatively higher content of peroxidation-sensitive polyunsaturated fatty acids and the low antioxidative defense in brain tissue. There are two remarkable peroxisomal defects, one relating to α-oxidation of phytanic acid and the other to uptake of very long-chain fatty acids (VLCFAs) which lead to pathologically high tissue levels of such fatty acids. Both, the accumulation of phytanic acid and that of VLCFAs give an enlightening insight into harmful activities of fatty acids on neural cells, which possibly explain why evolution has prevented brain mitochondria from the equipment with significant β-oxidation enzymatic capacity.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cerebral energy metabolism; Fatty acids; Ketone bodies; Mitochondria; Phytanic acid; β-Oxidation

Mesh:

Substances:

Year:  2017        PMID: 28366720     DOI: 10.1016/j.neuint.2017.03.018

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  19 in total

1.  Determining the Bioenergetic Capacity for Fatty Acid Oxidation in the Mammalian Nervous System.

Authors:  Cory J White; Jieun Lee; Joseph Choi; Tiffany Chu; Susanna Scafidi; Michael J Wolfgang
Journal:  Mol Cell Biol       Date:  2020-04-28       Impact factor: 4.272

Review 2.  Astrocyte Bioenergetics and Major Psychiatric Disorders.

Authors:  Ivan V Maly; Michael J Morales; Mikhail V Pletnikov
Journal:  Adv Neurobiol       Date:  2021

Review 3.  Biological Potential, Gastrointestinal Digestion, Absorption, and Bioavailability of Algae-Derived Compounds with Neuroprotective Activity: A Comprehensive Review.

Authors:  Bruna Martins; Mónica Vieira; Cristina Delerue-Matos; Clara Grosso; Cristina Soares
Journal:  Mar Drugs       Date:  2022-05-28       Impact factor: 6.085

Review 4.  APOE in the bullseye of neurodegenerative diseases: impact of the APOE genotype in Alzheimer's disease pathology and brain diseases.

Authors:  Rosalía Fernández-Calle; Sabine C Konings; Javier Frontiñán-Rubio; Juan García-Revilla; Lluís Camprubí-Ferrer; Martina Svensson; Isak Martinson; Antonio Boza-Serrano; José Luís Venero; Henrietta M Nielsen; Gunnar K Gouras; Tomas Deierborg
Journal:  Mol Neurodegener       Date:  2022-09-24       Impact factor: 18.879

Review 5.  Lipid metabolism and storage in neuroglia: role in brain development and neurodegenerative diseases.

Authors:  Danying Yang; Xifeng Wang; Lieliang Zhang; Yang Fang; Qingcui Zheng; Xing Liu; Wen Yu; Shoulin Chen; Jun Ying; Fuzhou Hua
Journal:  Cell Biosci       Date:  2022-07-12       Impact factor: 9.584

Review 6.  Lipid metabolism and Alzheimer's disease: clinical evidence, mechanistic link and therapeutic promise.

Authors:  Fei Yin
Journal:  FEBS J       Date:  2022-01-07       Impact factor: 5.622

7.  Nitric Oxide-Dependent Protein Post-Translational Modifications Impair Mitochondrial Function and Metabolism to Contribute to Neurodegenerative Diseases.

Authors:  Tomohiro Nakamura; Stuart A Lipton
Journal:  Antioxid Redox Signal       Date:  2019-12-03       Impact factor: 8.401

Review 8.  Energetic dysfunction in sepsis: a narrative review.

Authors:  Sebastien Preau; Dominique Vodovar; Boris Jung; Steve Lancel; Lara Zafrani; Aurelien Flatres; Mehdi Oualha; Guillaume Voiriot; Youenn Jouan; Jeremie Joffre; Fabrice Uhel; Nicolas De Prost; Stein Silva; Eric Azabou; Peter Radermacher
Journal:  Ann Intensive Care       Date:  2021-07-03       Impact factor: 6.925

Review 9.  Glucose metabolic crosstalk and regulation in brain function and diseases.

Authors:  Shuai Zhang; Brittany Bolduc Lachance; Mark P Mattson; Xiaofeng Jia
Journal:  Prog Neurobiol       Date:  2021-06-10       Impact factor: 10.885

Review 10.  Lipid droplets in the nervous system.

Authors:  Isha Ralhan; Chi-Lun Chang; Jennifer Lippincott-Schwartz; Maria S Ioannou
Journal:  J Cell Biol       Date:  2021-06-21       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.